Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
May 01, 2011 (Vol. 31, No. 9)

Proteinchemist.com

URL:mach7.bluehill.com/proteinc
  • Protocols, good general information
  • Many glitches with analysis tools

Proteinchemist.com is somewhat like an online hardware store…except for people who care more about nondenaturing electrophoresis than drywall. There is a diverse mix of general information about various aspects of protein chemistry—such as membrane protein topology, dynamic light scattering, kinetics, and chromatography—and this is sprinkled with protocols for common laboratory procedures. There is also a compilation of analysis programs contained within the “Protein Chemist’s Tool Kit Page.” Although some of the tools are quite handy (the sequence relativizer, for instance, calculates the pI, molecular weight, and hydrophobicity of your protein), I encountered errors with some of the tools, and many of them also appeared to be inexplicably restricted. Hopefully these glitches will be fixed in the near future, as the site does have a lot to offer for those who find themselves partial to proteins.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »